Results showed that a dry powder inhaler loaded with umeclidinium and vilanterol produced a 14% lower risk of moderate or severe COPD flare-ups, compared to a metered-dose inhaler loaded with ...

New research from UCLA Health suggests that certain inhalers used to treat chronic obstructive pulmonary disease (COPD) are ...

United Therapeutics reported a fourth-quarter net income of $364.3 million, or $7.70 a share, compared with $301.3 million, or $6.19 a share, a year earlier. The results beat Wall Street's forecast ...

Please provide your email address to receive an email when new articles are posted on . “Many health care systems are discussing a transition to dry-powder inhalers that have a lower carbon footprint ...

Findings based on comparison to glycopyrrolate-formoterol and tiotropium-olodaterol in patients newly prescribed LAMA-LABA inhalers.

United Therapeutics (NASDAQ:UTHR) used its fourth-quarter 2025 corporate update webcast to highlight what executives described as a set of near-term product and clinical milestones aimed at reshaping ...

Investing.com -- MannKind Corporation (NASDAQ:MNKD) shares fell 37% Wednesday after partner United Therapeutics unveiled a soft-mist inhaler that will compete with dry powder inhalation therapies.

Switching from a metered-dose to a dry-powder inhaler after a formulary change increased emergency department visits and hospitalizations in people with COPD or asthma. The absolute changes in risk ...

Most people with asthma and other lung diseases have no idea that commonly prescribed inhalers are helping make the planet warmer. Each puff has about the same climate impact as driving a gas-powered ...

Dr. Miguel Divo, a lung specialist at Brigham and Women’s Hospital, sits in an exam room, across from one of his patients with asthma. Joel Rubinstein, a retired psychiatrist, is about to get a ...

During an asthma check-up at Brigham and Women's Hospital in Boston, Joel Rubinstein gets a surprising pitch — for the planet, as well as his health. His pulmonologist, Dr. Miguel Divo, explains that ...